154 related articles for article (PubMed ID: 17030904)
1. Treatment of plague: promising alternatives to antibiotics.
Anisimov AP; Amoako KK
J Med Microbiol; 2006 Nov; 55(Pt 11):1461-1475. PubMed ID: 17030904
[TBL] [Abstract][Full Text] [Related]
2. Pneumonic Plague: The Darker Side of Yersinia pestis.
Pechous RD; Sivaraman V; Stasulli NM; Goldman WE
Trends Microbiol; 2016 Mar; 24(3):190-197. PubMed ID: 26698952
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic Therapy of Plague: A Review.
Sebbane F; Lemaître N
Biomolecules; 2021 May; 11(5):. PubMed ID: 34065940
[TBL] [Abstract][Full Text] [Related]
4. In vivo transcriptional profiling of Yersinia pestis reveals a novel bacterial mediator of pulmonary inflammation.
Pechous RD; Broberg CA; Stasulli NM; Miller VL; Goldman WE
mBio; 2015 Feb; 6(1):e02302-14. PubMed ID: 25691593
[TBL] [Abstract][Full Text] [Related]
5. Circumventing Y. pestis Virulence by Early Recruitment of Neutrophils to the Lungs during Pneumonic Plague.
Vagima Y; Zauberman A; Levy Y; Gur D; Tidhar A; Aftalion M; Shafferman A; Mamroud E
PLoS Pathog; 2015 May; 11(5):e1004893. PubMed ID: 25974210
[TBL] [Abstract][Full Text] [Related]
6. Bacteriophage-resistant mutants in Yersinia pestis: identification of phage receptors and attenuation for mice.
Filippov AA; Sergueev KV; He Y; Huang XZ; Gnade BT; Mueller AJ; Fernandez-Prada CM; Nikolich MP
PLoS One; 2011; 6(9):e25486. PubMed ID: 21980477
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of plague prophylaxis with streptomycin, tetracycline, and rifampicin in simultaneous immunization of white mice by resistant EV NRIEG strain].
Ryzhko IV; Tsuraeva RI; Moldavan IA; Shcherbaniuk AI
Antibiot Khimioter; 2004; 49(1):17-21. PubMed ID: 15164519
[TBL] [Abstract][Full Text] [Related]
8. Combinational deletion of three membrane protein-encoding genes highly attenuates yersinia pestis while retaining immunogenicity in a mouse model of pneumonic plague.
Tiner BL; Sha J; Kirtley ML; Erova TE; Popov VL; Baze WB; van Lier CJ; Ponnusamy D; Andersson JA; Motin VL; Chauhan S; Chopra AK
Infect Immun; 2015 Apr; 83(4):1318-38. PubMed ID: 25605764
[TBL] [Abstract][Full Text] [Related]
9. Yersinia pestis and the plague.
Rollins SE; Rollins SM; Ryan ET
Am J Clin Pathol; 2003 Jun; 119 Suppl():S78-85. PubMed ID: 12951845
[TBL] [Abstract][Full Text] [Related]
10. A Deadly Path: Bacterial Spread During Bubonic Plague.
Gonzalez RJ; Miller VL
Trends Microbiol; 2016 Apr; 24(4):239-241. PubMed ID: 26875618
[TBL] [Abstract][Full Text] [Related]
11. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.
Arnaboldi PM; Sambir M; D'Arco C; Peters LA; Seegers JF; Mayer L; McCormick AA; Dattwyler RJ
Vaccine; 2016 Nov; 34(47):5768-5776. PubMed ID: 27745954
[TBL] [Abstract][Full Text] [Related]
12. Oral vaccination against plague using Yersinia pseudotuberculosis.
Demeure CE; Derbise A; Carniel E
Chem Biol Interact; 2017 Apr; 267():89-95. PubMed ID: 27046452
[TBL] [Abstract][Full Text] [Related]
13. A plasminogen-activating protease specifically controls the development of primary pneumonic plague.
Lathem WW; Price PA; Miller VL; Goldman WE
Science; 2007 Jan; 315(5811):509-13. PubMed ID: 17255510
[TBL] [Abstract][Full Text] [Related]
14. Spatially distinct neutrophil responses within the inflammatory lesions of pneumonic plague.
Stasulli NM; Eichelberger KR; Price PA; Pechous RD; Montgomery SA; Parker JS; Goldman WE
mBio; 2015 Oct; 6(5):e01530-15. PubMed ID: 26463167
[TBL] [Abstract][Full Text] [Related]
15. Phage Therapy Potentiates Second-Line Antibiotic Treatment against Pneumonic Plague.
Vagima Y; Gur D; Aftalion M; Moses S; Levy Y; Makovitzki A; Holtzman T; Oren Z; Segula Y; Fatelevich E; Tidhar A; Zauberman A; Rotem S; Mamroud E; Steinberger-Levy I
Viruses; 2022 Mar; 14(4):. PubMed ID: 35458417
[TBL] [Abstract][Full Text] [Related]
16. Live-attenuated Yersinia pestis vaccines.
Wang X; Zhang X; Zhou D; Yang R
Expert Rev Vaccines; 2013 Jun; 12(6):677-86. PubMed ID: 23750796
[TBL] [Abstract][Full Text] [Related]
17. Delayed inflammatory response to primary pneumonic plague occurs in both outbred and inbred mice.
Bubeck SS; Cantwell AM; Dube PH
Infect Immun; 2007 Feb; 75(2):697-705. PubMed ID: 17101642
[TBL] [Abstract][Full Text] [Related]
18. Yersinia pestis Exploits Early Activation of MyD88 for Growth in the Lungs during Pneumonic Plague.
Olson RM; Dhariwala MO; Mitchell WJ; Anderson DM
Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30642901
[No Abstract] [Full Text] [Related]
19. Identification of New Virulence Factors and Vaccine Candidates for
Andersson JA; Sha J; Erova TE; Fitts EC; Ponnusamy D; Kozlova EV; Kirtley ML; Chopra AK
Front Cell Infect Microbiol; 2017; 7():448. PubMed ID: 29090192
[TBL] [Abstract][Full Text] [Related]
20. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.
Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE
PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
